0000929638-24-004038.txt : 20241125
0000929638-24-004038.hdr.sgml : 20241125
20241125110318
ACCESSION NUMBER: 0000929638-24-004038
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20241118
FILED AS OF DATE: 20241125
DATE AS OF CHANGE: 20241125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Biosion, Inc.
CENTRAL INDEX KEY: 0002045933
ORGANIZATION NAME:
STATE OF INCORPORATION: F4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 241492934
BUSINESS ADDRESS:
STREET 1: 5TH FLOOR, BUILDING D
STREET 2: 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD
CITY: NANJING
STATE: F4
ZIP: 210061
BUSINESS PHONE: 267-356-9574
MAIL ADDRESS:
STREET 1: 5TH FLOOR, BUILDING D
STREET 2: 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD
CITY: NANJING
STATE: F4
ZIP: 210061
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 LEE ROAD
STREET 2: SUITE 103
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 701 LEE ROAD
STREET 2: SUITE 103
CITY: WAYNE
STATE: PA
ZIP: 19087
3
1
form3.xml
X0206
3
2024-11-18
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0002045933
Biosion, Inc.
5TH FLOOR, BUILDING D
3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD
NANJING
F4
210061
CHINA
true
Warrants (right to buy)
0.0001
2024-11-18
Common Stock
11281985
D
On November 18, 2024, Aclaris Therapeutics, Inc. ("Aclaris") and Biosion, Inc. ("Biosion") entered into a Common Stock Purchase Warrant (the "Warrant"). Pursuant to the Warrant, Biosion, its designee or its permitted assigns, upon meeting certain terms and conditions of the Warrant, is entitled to exercise the warrant for up to 11,281,985 shares of Aclaris Common Stock. The Warrant was exercisable as of November, 18 2024 and may be exercised until the date on which the Warrant is exercised in full.
/s/ Biosion, Inc. by: MINGJIU CHEN, CEO
2024-11-25